Elite Pharmaceuticals Inc /nv/ sold $262k of ELTP
EVP Operations at ELITE PHARMACEUTICALS INC /NV/. 500,000 shares at an average of $0.52, traded Aug 22, 2025, filed Aug 26, 2025.
Score components
- +15RoleOfficer
- +13Trade size$262k at market
- +5Share of holdings soldSold 22% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +14.5%, 3m -3.6%, 6m -25.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-25-012347, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 22, 2025 | SOpen-market sale Common Stock | -500,000 | $0.52 | $262k | 1,800,000 | Aug 26, 2025 |
| Aug 25, 2025 | MOption exercise Common Stock | +2,500,000 | $0.03 | $75k | 4,300,000 | Aug 26, 2025 |
| Aug 25, 2025 | MOption exercise Stock Options (right to buy)derivative | -2,500,000 | $0.00 | $0 | 2,500,000 | Aug 26, 2025 |
Related signals
Other insiders at ELITE PHARMACEUTICALS INC /NV/ and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | ELTPbuy ELITE PHARMACEUTICALS INC /NV/ | Barry H Dash director | $8,610 30,000 shares | +1% | |
| 38Weak | ELTPsell ELITE PHARMACEUTICALS INC /NV/ | Douglas Plassche EVP Operations | $499k 800,000 shares | -19% | |
| 31Weak | ELTPbuy ELITE PHARMACEUTICALS INC /NV/ | Kirko Kirkov Chief Commercial Officer | $9,640 16,366 shares | - | |
| 25Weak | ELTPsell ELITE PHARMACEUTICALS INC /NV/ | Douglas Plassche EVP Operations | $116k 200,000 shares | -8% | |
| 54Moderate | ELTPsell ELITE PHARMACEUTICALS INC /NV/ | Douglas Plassche SVP of Operations | $562k 1,133,932 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.